Camber Capital Management LP Novartis Ag Transaction History
Camber Capital Management LP
- $4.32 Billion
- Q4 2024
A detailed history of Camber Capital Management LP transactions in Novartis Ag stock. As of the latest transaction made, Camber Capital Management LP holds 1,000,000 shares of NVS stock, worth $109 Million. This represents 3.01% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$109 Million% of portfolio
3.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$893 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$749 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$608 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...